Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
Background Immunotherapy and sorafenib exert anti-tumor effects via ferroptosis, but reliable biomarkers for the individual treatment and prognosis prediction of hepatocellular carcinoma (HCC) based on the ferroptosis and immune status remain lacking. Methods Ferroptosis-related genes (FRGs) were id...
Enregistré dans:
Auteurs principaux: | , , , , , |
---|---|
Format: | Artigo |
Langue: | anglais |
Publié: |
2020
|
Accès en ligne: | https://doi.org/10.3389/fcell.2020.596679 https://www.frontiersin.org/articles/10.3389/fcell.2020.596679/pdf |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|